×
Your location has been changed to Boston area.
Tuesday, May 21, 2024 - 9:00 AM
to Thursday, May 23, 2024 - 2:00 PM
9:00 AM - 2:00 PM See all dates and Times
Categories
The FDA Modernization Act 2.0 has triggered a new mindset for pharma, with Roche launching the Institute of Human Biology to create better models, and MSD collaborating with Inventia to bioprint 3D in vitro models to screen for neurodegenerative therapeutic candidates.
It has never been a more exciting time to bet on 3D tissue models as the future of drug development, as more and more complex in vitro models undergo validation. However, the big question of “when can we have the confidence in standalone 3D models, and how to do it at scale?” persists.
Making its timely return to Boston this May, the 9th 3D Tissue Models Summit will enable you and your team to uncover best practices across 23+ real-world applications of complex in vitro models across drug discovery and development. Join us to learn from and meet the ‘front-line’ experts optimizing and leveraging advanced 3D models to confidently empower your own drug development workflows.
Event Links
Website: https://go.evvnt.com/2224592-0
Tickets: https://go.evvnt.com/2224592-2
Brochure: https://go.evvnt.com/2224592-3